Background: Mitochondrial disorders are heterogeneous clinical syndromes caused by defective activity in the mitochondrial respiratory chain, resulting in a faulty oxidative phosphorylation system. These inherited disorders are individually rare, and furthermore they are phenotypic variables. The genetically characterized mitochondrial disorders are rarely associated with epileptic encephalopathies. Case presentation: We present the clinical phenotype, biochemical analysis, and electrographic and neuro-radiological features of a 5-month-old girl with epileptic encephalopathy, microcephaly, severe psychomotor delay, hypertrophic cardiomyopathy, and abnormal MRI scan. Using whole-genome sequencing technique, compound heterozygous mutations of the VARS2 gene were revealed, with one previously unreported frameshift mutation. Conclusion: Our report extends the phenotypic spectrum of VARS2-related disorders with an initial presentation of epileptic encephalopathy and early death due to malignant arrhythmia.
We aimed to evaluate the diagnostic accuracy of the proinflammatory monocyte chemotactic protein-1 (MCP-1) in the diagnosis of asymptomatic diastolic dysfunction (DD) in patients with psoriatic arthritis (PsA). The disease activity in psoriatic arthritis (DAPSA) was determined using clinical and laboratory parameters, and echocardiography was performed to estimate DD. Serum MCP-1 concentrations were elevated in PsA patients with DD diagnosed with ultrasound (median (25th percentile, 75th percentile): 366.6 pg/mL (283, 407.1 pg/mL) vs. 277.5 pg/mL (223.5, 319.1 pg/mL) in controls; ). PsA patients with serum MCP-1 concentration higher than the cut-off value of 347.6 pg/mL had a 7.74-fold higher chance of developing DD than PsA patients with lower serum MCP-1 concentrations (controls), with a specificity of 86.36% and sensitivity of 55%, as verified using ultrasound. The group with MCP-1 concentrations above the cut-off value also showed a higher late peak diastolic mitral inflow velocity, A-wave value ( ), E/E ratio ( ), and a lower E/A ratio ( ), peak systolic left atrial reservoir strain, SA value ( ), early peak diastolic displacement of the mitral septal annulus, E wave value ( ), than controls. Systolic blood pressure ( ), LDL cholesterol concentration ( ), glucose concentration ( ), and DAPSA ( ) increased in the PsA group with higher MCP-1 concentrations, although there were no differences in comorbidities and therapy between the groups compared. Thus, the serum MCP-1 concentration was a significant and independent prognostic indicator for asymptomatic DD in PsA patients (
The group of spondyloarthritis (SpA) disorders shares common clinical manifestations, including internal derangement (ID) of temporomandibular joint (TMJ). This study aimed to investigate SpA activity in patients with ID of TMJ. We assessed 200 patients with neck pain using the Assessment of Spondyloarthritis International Society (ASAS) criteria. TMJ was examined using Diagnostic Criteria for Temporomandibular Disorders (DC/TMD protocol). Patients with SpA were divided into three groups: symptomatic ID of TMJ, asymptomatic ID of TMJ, or healthy TMJ (controls). Activity of SpA was evaluated using the Ankylosing Spondylitis Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Disease Activity Index in Psoriatic Arthritis (DAPSA), patients' self-estimated SpA activity, difficulties in performing daily activities, pain intensity (visual analogue scale) and laboratory parameters. Patients with symptomatic and asymptomatic ID showed statistically significantly increased ASDAS, anti-streptolysin titer, patients' self-estimated axial pain and activity of SpA, and decreased hematocrit than the control. Patients with symptomatic ID also had statistically significant earlier onset of SpA, along with increased BASDAI and DAPSA, total body pain, difficulties in performing daily activities, platelet count, and serum alpha-amylase but lower hemoglobin concentration than controls. Patients with asymptomatic ID had higher frequencies of exacerbated axial SpA and sacroiliac joint ankylosis compared to the control. All patients with SpA and ID showed increased axial disease activity.
IntroductionA significant amount of evidence from structural brain imaging studies provide new insights into the neuroanatomical basis of schizophrenia.ObjectivesTo investigate whole brain gray matter (GM) differences between schizophrenia patients grouped according to the number of psychotic episodes and normal controls (NC).AimTo determine regions of GM differences in schizophrenia patients grouped according to the number of psychotic episodes.MethodsA group of 53 schizophrenia patients (23 with up to 3 psychotic episodes, 15 with 4 to 6 and 15 with 7 or more psychotic episodes) and 35 age and gender matched NC were included. Voxel-based morphometry (VBM) is an adaptation of the statistical parametric mapping technique that allows investigators to quantitatively examine brain structural changes. VBM data of schizophrenia patients divided into 3 groups: up to 3, 4 to 6 and 7 or more episodes were compared with NC.ResultsPatients with up to 3 episodes had reduced gray matter volume (GMV) in the right claustrum, right Brodmann areas 6 and 13 and left Brodmann area 10, patients with 4 to 6 episodes in left Brodmann areas 25, 35 and 37 and in right Brodmann area 13, and those with 7 or more episodes showed decreased GMV in left substantia nigra and left Brodmann area 10 compared with NC.ConclusionGMV reduction in schizophrenia varies depending on the number of psychotic episodes. The affection of different brain areas indicates separated neurobiological mechanisms underlying the stage and the progression of illness.